Glenmark Pharmaceuticals

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue3,1043,5403,3343,0563,209
Expenses2,7683,1033,0252,8523,008
EBITDA565.33696.66564.75457.07463.98
EBIT419.56568.27-381.51263.01-2.89
Profit Before Tax336.62470.99-490.77151.40-124.35
Net Profit278.67290.76-403.14173.13-61.56
Financial Ratios
Operating Profit Margin18.95%21.54%-7.12%13.51%4.38%
Net Profit Margin8.73%7.42%6.19%6.08%6.65%
Earning Per Share (Diluted)9.239.66-15.185.31-7.11
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ